We all know about DEG and it’s amazing performance this year due to assay results. CAD and KAI seem to be its nearest neighbours, however, my reading suggests that CAD seems to be the closest to DEG’s hotspots, please correct me if I’m wrong. What are everyone thoughts on owning parcels of this Pilbara threesome? Do we see CAD and KAI as being in for a good chance to performing like DEG? Are they simply just 6 months behind DEG in discoveries and announcements? It seems to me that owning all three should, and I stress ‘should’ be a recipe for some decent long term growth. Thoughts?
CAD and KAI relevance to DEG.
Add MTL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.296M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 142 | 446440921 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 21157694 | 21 |
View Market Depth
| Last trade - 16.12pm 26/04/2024 (20 minute delay) ? |
| MTL (ASX) Chart |
Day chart unavailable